Auxora

DRUG2 trials

Sponsors

CalciMedica, Inc.

Conditions

Acute Kidney InjuryPneumonia

Phase 2

A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia

WithdrawnNCT05171920

CalciMedica, Inc.Pneumonia

Start: 2022-01-24End: 2022-07-31Updated: 2022-03-31

A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"

TerminatedNCT06374797

CalciMedica, Inc.Acute Kidney Injury

Start: 2024-07-01End: 2026-04-06Updated: 2026-08-31

Related Papers

Inhibition of Calcium Release-Activated Calcium (CRAC) channels to Treat Acute Kidney Injury: Design and Rationale of the KOURAGE study

American Journal of Nephrology2025-06-091 citations